http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104069502-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 |
| filingDate | 2013-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104069502-B |
| titleOfInvention | Compound skeleton material and its pharmaceutical composition |
| abstract | The present invention relates to a kind of compound skeleton material and the pharmaceutical composition of the compound skeleton material is included, the compound skeleton material is used for the purposes for preparing medicament slow release preparation, and the preparation method of described pharmaceutical composition.Specifically, the compound skeleton material includes hydrophobic skeleton material and hydrophilic back bone material, and the proportion of wherein hydrophobic skeleton material and hydrophilic back bone material is 1: 0.01 to 1: 5, preferably 1: 0.05 to 1: 4, more preferably 1: 0.1 to 1: 3, most preferably 1: 0.4 to 1: 2.Described pharmaceutical composition includes compound skeleton material of the present invention and one or more active constituents of medicine, preferably, the proportion of compound skeleton material and active constituents of medicine is 1: 0.01 to 1: 8, more preferably 1: 0.02 to 1: 5, most preferably 1: 0.03 to 1: 1. |
| priorityDate | 2013-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.